Probable phospholipid-transporting ATPase IIB is a member of the P-type ATPase family, which are membrane proteins known to transport ions and lipids across cellular membranes using the energy found in ATP hydrolysis. This particular ATPase, as suggested by its name, is involved in the translocation of phospholipids from one leaflet of the membrane bilayer to the other, a process commonly referred to as "flipping".These ATPases play a crucial role in maintaining the asymmetric distribution of phospholipids in the lipid bilayer, which is essential for various cellular processes such as vesicle formation, blood coagulation, and apoptosis. The asymmetric distribution of lipids, especially in the plasma membrane, contributes to the membrane's curvature and affects the interaction with proteins and other cellular components. It is also key in the process of cell signaling.
The probable phospholipid-transporting ATPase IIB likely has a similar structure to other P-type ATPases, with transmembrane domains that form the pathway for substrate movement and cytoplasmic domains that bind and hydrolyze ATP to drive the transport process. These enzymes are characterized by a conserved autophosphorylation site, where a conserved aspartate residue in the active site is transiently phosphorylated during the transport cycle.These ATPases are also known for their specificity in lipid substrate selection, which can include phosphatidylserine, phosphatidylethanolamine, and sometimes phosphatidylcholine. The activity of these enzymes is tightly regulated by various factors, including the lipid composition of the membrane, the presence of specific lipid microdomains, and interactions with other proteins.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin indirectly enhances ATP8B2 activity by increasing intracellular cAMP levels, which can modulate various ATPases. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP) is a cAMP analog that indirectly activates ATP8B2 by mimicking cAMP's cellular effects. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) increases cAMP by inhibiting phosphodiesterases, indirectly influencing ATP8B2 activity. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide, a phosphodiesterase inhibitor, raises cAMP levels, potentially affecting ATP8B2 indirectly. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, another phosphodiesterase inhibitor, can enhance cAMP levels, thereby possibly impacting ATP8B2. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone increases cAMP by inhibiting phosphodiesterase-3, which may indirectly activate ATP8B2. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine stimulates adenylyl cyclase, leading to increased cAMP and potential indirect effects on ATP8B2. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a β-adrenergic agonist, increases cAMP levels, potentially influencing ATP8B2 activity. | ||||||
Dobutamine | 34368-04-2 | sc-507555 | 100 mg | $295.00 | ||
Dobutamine, through β-adrenergic receptor activation, can raise cAMP levels, indirectly affecting ATP8B2. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline, a β2-adrenergic receptor agonist, raises cAMP levels, potentially affecting ATP8B2 indirectly. | ||||||